Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Mylan's Morphine Sulfate Extended-release (ER) Tablets' abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Mylan’s Morphine Sulfate ER tablets are available in different doses including 5 mg, 30 mg, 60 mg, 100 mg and 200 mg.
Morphine Sulfate ER Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg are generic equivalent to Purdue Pharma’s MS Contin, an opioid analgesic for moderate to severe pain management.